- Home
- CUBA vs ELEV Comparison
CUBA vs ELEV Comparison
Compare CUBA & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUBA
- ELEV
- Stock Information
- Founded
- CUBA 1992
- ELEV 2019
- Country
- CUBA United States
- ELEV United States
- Employees
- CUBA N/A
- ELEV N/A
- Industry
- CUBA Investment Managers
- ELEV Biotechnology: Pharmaceutical Preparations
- Sector
- CUBA Finance
- ELEV Health Care
- Exchange
- CUBA Nasdaq
- ELEV Nasdaq
- Market Cap
- CUBA 38.4M
- ELEV 37.6M
- IPO Year
- CUBA N/A
- ELEV 2021
- Fundamental
- Price
- CUBA $2.37
- ELEV $0.61
- Analyst Decision
- CUBA
- ELEV Buy
- Analyst Count
- CUBA 0
- ELEV 6
- Target Price
- CUBA N/A
- ELEV $7.20
- AVG Volume (30 Days)
- CUBA 93.9K
- ELEV 1.3M
- Earning Date
- CUBA 01-01-0001
- ELEV 03-05-2025
- Dividend Yield
- CUBA 20.83%
- ELEV N/A
- EPS Growth
- CUBA N/A
- ELEV N/A
- EPS
- CUBA N/A
- ELEV N/A
- Revenue
- CUBA N/A
- ELEV N/A
- Revenue This Year
- CUBA N/A
- ELEV N/A
- Revenue Next Year
- CUBA N/A
- ELEV N/A
- P/E Ratio
- CUBA N/A
- ELEV N/A
- Revenue Growth
- CUBA N/A
- ELEV N/A
- 52 Week Low
- CUBA $2.25
- ELEV $0.50
- 52 Week High
- CUBA $4.14
- ELEV $5.83
- Technical
- Relative Strength Index (RSI)
- CUBA 38.17
- ELEV 43.44
- Support Level
- CUBA $2.39
- ELEV $0.64
- Resistance Level
- CUBA $2.45
- ELEV $0.72
- Average True Range (ATR)
- CUBA 0.03
- ELEV 0.05
- MACD
- CUBA -0.01
- ELEV -0.00
- Stochastic Oscillator
- CUBA 7.14
- ELEV 18.41
About CUBA Herzfeld Caribbean Basin Fund Inc. (The)
Herzfeld Caribbean Basin Fund Inc operates as a closed-end management investment company. The company's investment objective is to obtain long-term capital appreciation. The firm offers customized discretionary account management and fund management services to individual and institutional investors. The fund invests in equity and equity-linked securities of public and private companies, including United States-based companies, whose securities are traded principally on a stock exchange in a Caribbean Basin Country. The fund's revenue source is through the dividends it receives. Its investments are geographically allocated in the United States followed by Mexico, Puerto Rico, and other countries.
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.